Avenir Wellness Solutions Inc (AVRW)
0.0439
+0.01
(+13.29%)
USD |
OTCM |
May 17, 13:23
Avenir Wellness Solutions Enterprise Value: 11.45M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 11.45M |
| May 16, 2024 | 11.07M |
| May 15, 2024 | 11.07M |
| May 14, 2024 | 10.66M |
| May 13, 2024 | 10.66M |
| May 10, 2024 | 10.66M |
| May 09, 2024 | 10.66M |
| May 08, 2024 | 10.92M |
| May 07, 2024 | 10.92M |
| May 06, 2024 | 10.66M |
| May 03, 2024 | 11.09M |
| May 02, 2024 | 10.65M |
| May 01, 2024 | 10.65M |
| April 30, 2024 | 11.07M |
| April 29, 2024 | 11.53M |
| April 26, 2024 | 11.53M |
| April 25, 2024 | 11.90M |
| April 24, 2024 | 10.62M |
| April 23, 2024 | 11.24M |
| April 22, 2024 | 11.24M |
| April 19, 2024 | 11.34M |
| April 18, 2024 | 11.17M |
| April 17, 2024 | 10.58M |
| April 16, 2024 | 10.58M |
| April 15, 2024 | 10.80M |
| Date | Value |
|---|---|
| April 12, 2024 | 10.91M |
| April 11, 2024 | 10.91M |
| April 10, 2024 | 10.91M |
| April 09, 2024 | 11.11M |
| April 08, 2024 | 10.91M |
| April 05, 2024 | 10.59M |
| April 04, 2024 | 10.58M |
| April 03, 2024 | 10.46M |
| April 02, 2024 | 10.46M |
| April 01, 2024 | 10.46M |
| March 28, 2024 | 10.46M |
| March 27, 2024 | 10.46M |
| March 26, 2024 | 10.46M |
| March 25, 2024 | 10.95M |
| March 22, 2024 | 10.95M |
| March 21, 2024 | 10.51M |
| March 20, 2024 | 10.47M |
| March 19, 2024 | 10.95M |
| March 18, 2024 | 10.95M |
| March 15, 2024 | 10.46M |
| March 14, 2024 | 10.89M |
| March 13, 2024 | 10.46M |
| March 12, 2024 | 10.50M |
| March 11, 2024 | 11.31M |
| March 08, 2024 | 11.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.46M
Minimum
Apr 01 2024
227.89M
Maximum
Jun 26 2019
55.37M
Average
43.87M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
| Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.224M |
| Revenue (Quarterly) | 1.015M |
| Total Expenses (Quarterly) | 2.569M |
| EPS Diluted (Quarterly) | -0.03 |
| Gross Profit Margin (Quarterly) | 72.61% |
| Profit Margin (Quarterly) | -219.1% |
| Earnings Yield | -325.6% |
| Normalized Earnings Yield | -251.20 |